Literature DB >> 14654220

Specific modification of heparan sulphate is required for normal cerebral cortical development.

David McLaughlin1, Fredrik Karlsson, Natasha Tian, Thomas Pratt, Simon L Bullock, Valerie A Wilson, David J Price, John O Mason.   

Abstract

Proteoglycans are cell surface and extracellular matrix molecules to which long, unbranched glycosaminoglycan side chains are attached. Heparan sulphate, a type of glycosaminoglycan chain, has been proposed as a co-factor necessary for signalling by a range of growth factors. Here we provide evidence that loss of 2-O-sulphation in heparan sulphate leads to a significant reduction in cell proliferation in the developing cerebral cortex. The gene encoding heparan sulphate 2-sulphotransferase (Hs2st) is expressed in embryonic cortex and histological analysis of mice homozygous for a null mutation in Hs2st indicated a reduction in the thickness of the embryonic cerebral cortex. Using 5'-bromodeoxyuridine (BrdU) incorporation assays we found a reduction of approximately 40% in labelling indices of cortical precursor cells at E12. Comparison of the fates of cortical cells born on E13 and E15 in Hs2st(-/-) mutant and wildtype littermate embryos revealed no differences in the pattern of cell migration. Our findings suggest a critical role for 2-O-sulphation of heparan sulphate proteoglycan (HSPG) in regulating cell proliferation during development of the cerebral cortex, perhaps through the modulation of cellular responses to growth factor signalling.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14654220     DOI: 10.1016/j.mod.2003.08.008

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  21 in total

1.  Analysis of axon guidance defects at the optic chiasm in heparan sulphate sulphotransferase compound mutant mice.

Authors:  Christopher D Conway; David J Price; Thomas Pratt; John O Mason
Journal:  J Anat       Date:  2011-09-26       Impact factor: 2.610

2.  Heparan sulfate expression in the neural crest is essential for mouse cardiogenesis.

Authors:  Yi Pan; Christian Carbe; Sabine Kupich; Ute Pickhinke; Stefanie Ohlig; Maike Frye; Ruth Seelige; Srinivas R Pallerla; Anne M Moon; Roger Lawrence; Jeffrey D Esko; Xin Zhang; Kay Grobe
Journal:  Matrix Biol       Date:  2013-11-05       Impact factor: 11.583

Review 3.  Glycan susceptibility factors in autism spectrum disorders.

Authors:  Chrissa A Dwyer; Jeffrey D Esko
Journal:  Mol Aspects Med       Date:  2016-07-11

Review 4.  Deciphering functional glycosaminoglycan motifs in development.

Authors:  Robert A Townley; Hannes E Bülow
Journal:  Curr Opin Struct Biol       Date:  2018-03-24       Impact factor: 6.809

Review 5.  Functions of chondroitin sulfate and heparan sulfate in the developing brain.

Authors:  N Maeda; M Ishii; K Nishimura; K Kamimura
Journal:  Neurochem Res       Date:  2010-11-26       Impact factor: 3.996

Review 6.  Heparan sulfate proteoglycans.

Authors:  Stephane Sarrazin; William C Lamanna; Jeffrey D Esko
Journal:  Cold Spring Harb Perspect Biol       Date:  2011-07-01       Impact factor: 10.005

7.  Cerebral hypoplasia and craniofacial defects in mice lacking heparan sulfate Ndst1 gene function.

Authors:  Kay Grobe; Masaru Inatani; Srinivas R Pallerla; Jan Castagnola; Yu Yamaguchi; Jeffrey D Esko
Journal:  Development       Date:  2005-07-14       Impact factor: 6.868

8.  The winged helix transcription factor Foxg1 facilitates retinal ganglion cell axon crossing of the ventral midline in the mouse.

Authors:  Thomas Pratt; Natasha M M-L Tian; T Ian Simpson; John O Mason; David J Price
Journal:  Development       Date:  2004-07-07       Impact factor: 6.868

Review 9.  Flexible Roles for Proteoglycan Sulfation and Receptor Signaling.

Authors:  Panpan Yu; Craig S Pearson; Herbert M Geller
Journal:  Trends Neurosci       Date:  2017-11-14       Impact factor: 13.837

10.  Visualizing mechanosensory endings of TrkC-expressing neurons in HS3ST-2-hPLAP mice.

Authors:  Hiroshi Hasegawa; Fan Wang
Journal:  J Comp Neurol       Date:  2008-12-01       Impact factor: 3.215

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.